Indefinite Delivery Contract SPE2DX15D3923

The Indefinite Delivery Contract (IDC) SPE2DX15D3923 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC, valued at up to $999,999,999.00, enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies to support military treatment facilities and programs worldwide. Key products include specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials. Amerisourcebergen, as a major pharmaceutical distributor, leverages its extensive supply chain to fulfill delivery orders for these essential medical commodities. The contract has a period of performance through December 31, 2025. Amerisourcebergen also holds a smaller IDC valued at up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar pharmaceutical and medical products. These IDCs demonstrate the company's capacity to meet the diverse healthcare needs of multiple government agencies on a large scale.

In addition, Amerisourcebergen has been awarded other notable federal contracts, such as a $7,570,000 definitive contract with the Office of the Assistant Secretary for Preparedness and Response for H-CORE Therapeutic & Vaccine Vendor Managed Inventory, Distribution and Destruction services. The company's federal contracting activities primarily focus on supplying essential medical products to military treatment facilities, veterans' hospitals, and other government healthcare providers nationwide, supporting the overall healthcare needs of military personnel, veterans, and other federal beneficiaries.